The pharma giant wants to refreshen its portfolio after some of its internal development programs disappointed in clinical ...

Sanofi agreed to buy Blueprint Medicines for up to $9.5 billion, the French drugmaker's biggest move yet to replenish its drug pipeline since it sold a controlling stake in its consumer-healthcare arm ...

A readily available sleep aid has been shown to have a surprising side effect on brain health, seemingly protecting the organ ...

Hudson has previously said he was looking for M&A deals this year to shore up its already-strong position in immunology, ...

Data presented at ASCO show that swapping in the oral drug camizestrant for an older therapy helped sustain the benefit of ...

An colon cancer study highlighted the importance of the National Cancer Institute, while cancer doctors got a look at a ...

Baulieu, the French scientist who developed the abortion pill, mifepristone, died at 98. His groundbreaking work transformed ...

TURKU, FI / ACCESS Newswire / June 2, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Favorable response rates and survival data in high/very high-risk frontline and r/r MDS support advancement ...